We are live on ! Find out more

55 hedge funds and large institutions have $3.78M invested in PAVmed in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $52K | Put options by funds: $12K

1% more capital invested

Capital invested by funds: $3.76M → $3.78M (+$24.8K)

0% less ownership

Funds ownership: 0.02%0.02% (-0%)

5% less funds holding

Funds holding: 5855 (-3)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
9
Reduced
13
Closed
6
Calls
$52K
Puts
$12K
Net Calls
+$40K
Net Calls Change
-$17K

PAVM Hedge Fund Activity: Q2 2023 in Review

55 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2023, worth a combined $3.78M — up 0.66% from $3.76M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PAVM and 3 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 9 added.

The largest buyer was Charles Schwab, opening a new position worth an estimated $35.4K. The largest seller was Verition Fund Management, cutting an estimated $122K.

  • 55 institutional investors held PAVmed (PAVM) as of Q2 2023, down from 58 in Q1 2023.
  • Funds reported $3.78M of PAVmed stock for Q2 2023, up 0.66% quarter-over-quarter.
  • 3 funds opened new PAVmed positions in Q2 2023 and 6 closed out, a net change of -3 holders.
  • The largest PAVmed buyer in Q2 2023 was Charles Schwab, an estimated $35.4K added.
  • The largest PAVmed seller in Q2 2023 was Verition Fund Management, an estimated $122K sold.

Based on aggregated 13F filings for Q2 2023.